Primary ciliary dyskinesia. Clinical observation

por T. B. Pavlova, V. M. Shinkaryova
Publicado 2016

Pseudocyst of the auricle in patients with movement disorders: report of two patients with ataxia-associated auricular pseudocysts

por Bryce D. Beutler, Philip R. Cohen
Publicado 2015

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong

por Werner Poewe, Angelo Antonini, Jan CM Zijlmans, et al
Publicado 2010

ДИФФЕРЕНЦИРОВАННОЕ КОМПЛЕКСНОЕ ЛЕЧЕНИЕ ПАЦИЕНТОВ, СТРАДАЮЩИХ БОЛЕЗНЬЮ ПАРКИНСОНА, С УЧЁТОМ СТЕПЕНИ АТРОФИЧЕСКИХ ИЗМЕНЕНИЙ ВЕЩЕСТВА ГОЛОВНОГО МОЗГА...

por V. A. Chipizubov, S. I. Petrov, I. M. Mikhalevich
Publicado 2017

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia

por Kumsa A, Girma S, Alemu B, Agenagnew L
Publicado 2020

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats

por Cao,Xuebing, Hou,Dongzhi, Wang,Lei, Li,Sai, Sun,Shengang, Ping,Qineng, Xu,Yan
Publicado 2016

A Study on the Genetics of Primary Ciliary Dyskinesia

por Mohammed T. Alsamri, Amnah Alabdouli, Durdana Iram, Alia M. Alkalbani, Ayesha S. Almarzooqi, Abdul-Kader Souid, Ranjit Vijayan
Publicado 2021

International veterinary canine dyskinesia task force ECVN consensus statement: Terminology and classification

por Sofia Cerda‐Gonzalez, Rebecca A. Packer, Laurent Garosi, Mark Lowrie, Paul J. J. Mandigers, Dennis P. O'Brien, Holger A. Volk
Publicado 2021

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease

por A Ahmadi Ahangar, SAR Sadraei Mousavi
Publicado 2002

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review

por Yi Wu, Xue-bing Cao, Wei-qi Zeng, Heng Zhai, Xiao-qian Zhang, Xiao-man Yang, Chi Cheng, Jia-ling Wang, Xiao-mei Yang, Yan Xu
Publicado 2021

Identification of Two Novel DNAAF2 Variants in Two Consanguineous Families with Primary Ciliary Dyskinesia

por Lu C, Yang D, Lei C, Wang R, Guo T, Luo H
Publicado 2021

Case Report: Long-Term Suppression of Paroxysmal Kinesigenic Dyskinesia After Bilateral Thalamotomy

por Masato Murakami, Shiro Horisawa, Kenko Azuma, Hiroyuki Akagawa, Taku Nonaka, Takakazu Kawamata, Takaomi Taira
Publicado 2021

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats

por Wu N, Song L, Yang X, Yuan W, Liu Z
Publicado 2013

Bilateral Globus Pallidus Interna Combined With Subthalamic Nucleus Variable Frequency Deep Brain Stimulation in the Treatment of Young-Onset Parkinson's Disease With Refractory Dy...

por Bowen Chang, Bowen Chang, Bowen Chang, Jiaming Mei, Jiaming Mei, Jiaming Mei, Chi Xiong, Chi Xiong, Chi Xiong, Peng Chen, Peng Chen, Peng Chen, Manli Jiang, Manli Jiang, Manli Jiang, Chaoshi Niu, Chaoshi Niu, Chaoshi Niu
Publicado 2021

Implementing nitrogen multiple breath washout as a clinical tool – A feasibility study

por Carolina Constant, Andreia Descalço, Ana Margarida Silva, Luísa Pereira, Celeste Barreto, Teresa Bandeira
Publicado 2021

Tardive Dyskinesia in Older Persons Taking Antipsychotics

por Citrome L, Isaacson SH, Larson D, Kremens D
Publicado 2021

Post-stroke dyskinesias

por Nakawah MO, Lai EC
Publicado 2016

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?

por Hu JB, Lai JB, Hu SH, Xu Y
Publicado 2017

The safety issues and hardware-related complications of deep brain stimulation therapy: a single-center retrospective analysis of 478 patients with Parkinson’s disease

por Zhang J, Wang T, Zhang C, Zeljic K, Zhan S, Sun B, Li D
Publicado 2017

Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report

por Pan F, Li S, Li H, Xu Y, Huang M
Publicado 2018